Compare Access Protocol (ACS) vs Immunefi (IMU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Access Protocol vs Immunefi — how do they compare? Access Protocol trades at Rp2.27 (market cap Rp116,68M, Rp7,6M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Access Protocol is far larger — about 4.3× Immunefi's market cap, and Immunefi's supply is capped (873,4M / 10B IMU (9%)) while Access Protocol's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Access Protocol for 15 Days and Immunefi for 5 Days on average.
| ACS | IMU | |
|---|---|---|
Market Cap | Rp116,68M | Rp27,03M |
Volume (24h) | Rp7,6M | Rp39,91M |
Circulating Supply | 51,5B ACS | 873,4M / 10B IMU (9%) |
Typical Hold Time | 15 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Access Protocol (ACS) is trading at Rp2.2603 with a market cap of Rp117.49 million, showing a bearish technical signal overall. The moving averages are strongly bearish, while oscillators are neutral. Key indicators like RSI_6 at 14.50 suggest potential oversold conditions. No recent news is available, and the asset lacks major fundamental updates. The token's hold time is 15 days, indicating short-term trading activity.
The outlook remains cautious due to bearish technicals and low market cap, posing liquidity risks. Opportunities exist if oversold RSI leads to a rebound, but investors should monitor for protocol developments and exchange liquidity. Major risks include high volatility and regulatory uncertainties common in crypto assets.
Immunefi token shows limited market activity with a modest market cap of Rp27,03M and low circulation rate of 9%. The asset demonstrates minimal trading volume and network engagement, with token holders maintaining short 5-day holding periods. Recent coverage appears misaligned with the cryptocurrency's actual blockchain metrics, suggesting potential entity confusion.
Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunities include potential network growth, while major risks involve low adoption, regulatory uncertainty, and market volatility. Investors should monitor on-chain metrics for signs of genuine protocol activity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Access Protocol
Access Protocol provides a new method for digital media publications and content creators to monetize their work. Instead of traditional subscription payments, users stake the ACS token to gain access to premium digital content.
Read more on ACS →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
